Skip to main content
. 2023 Aug 31;29(2):66–72. doi: 10.6118/jmm.23006

Table 1. Baseline characteristics of study participants.

Low muscle mass
Normal (n = 976) Low muscle mass (n = 330) P value
Age (y) 69.48 ± 0.28 71.18 ± 0.49 0.003
Age of menopause (y) 55.04 ± 3 53.15 ± 3.37 0.677
Height (cm) 151.97 ± 0.22 150.92 ± 0.48 0.045
Weight (kg) 58.16 ± 0.4 49.83 ± 0.42 < 0.001
Waist circumference (cm) 85.46 ± 0.37 78.48 ± 0.53 < 0.001
BMI (kg/m2) 25.13 ± 0.15 21.85 ± 0.15 < 0.001
Fasting glucose (mg/dL) 103.17 ± 1.06 101.39 ± 1.60 0.362
HbA1c 6.45 ± 0.08 6.36 ± 0.13 0.549
Triglycerides 145.64 ± 3.40 138.56 ± 5.62 0.253
HDL cholesterol 47.3 ± 0.45 48.46 ± 0.87 0.235
LDL cholesterol 122.76 ± 2.59 128.61 ± 4.67 0.270
GOT 23.91 ± 0.47 21.53 ± 0.37 < 0.001
GPT 20.38 ± 0.45 16.63 ± 0.44 < 0.001
Alkaline phosphatase (IU/L) 260.65 ± 2.81 265.13 ± 4.75 0.405
Parathyroid hormone (pg/mL) 70.83 ± 1.37 74.38 ± 2.36 0.183
HTN medication (%) 53.38 (2.03) 51.05 (3.49) 0.552
DM medication (%) 15.14 (1.33) 16.34 (2.46) 0.646
DM (%) 0.912
Normal 58.16 (1.94) 58.99 (4.00)
Insulin resistance 22.24 (1.70) 20.83 (3.16)
DM 19.6 (1.48) 20.18 (2.99)
Alcohol (%) 0.174
None 72.17 (2.82) 75.77 (4.55)
Less than once a month 18.63 (2.47) 11.22 (3.17)
Once a month 5.47 (1.37) 6.87 (3.08)
Once a week 3.34 (1.21) 3.58 (1.78)
Every day 0.39 (0.29) 2.56 (1.91)
Smoking (%) 3.31 (0.59) 8.38 (2.06) 0.002
Parity (%) 98.6 (0.37) 98.58 (0.62) 0.980
COCP (%) 25.69 (1.68) 22.54 (2.70) 0.310
Use of hormones (%) 11.06 (1.21) 11.1 (1.89) 0.987
HTN stage (%) 0.397
Normal 10.72 (1.11) 13.49 (2.31)
Pre‑HTN 20.65 (1.46) 21.89 (2.65)
HTN 68.62 (1.74) 64.61 (3.17)

Values are presented as mean ± SD or number (%).

BMI: body mass index, HbA1c: glycated hemoglobin, HDL: high-density lipoprotein, LDL: low-density lipoprotein, GOT: glutamic oxaloacetic transaminase, GPT: glutamlc pyruvic transamlnase, HTN: hypertension, DM: diabetes mellitus, COCP: combined oral contraceptive pill.